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ABSTRACT 
  
Transforming Growth Factor β1 (TGFβ1) plays an important role in the maturation 
of megakaryocyte and formation of platelets. TGFβ1 can up-regulate Ca2+ entry 
through store operated Ca2+ entry (SOCE) and on the contrary, it can up-regulate Ca2+ 
exclusion by upregulating the activity of Na+/Ca2+ exchangers. TGFβ1 first enhances 
the increase of intracellular Ca2+ triggered by the release of Ca2+ from intracellular 
stores, then it enhances the subsequent decline of [Ca2+]i. 
The mechanism of action, by which TGFβ1 up-regulates SOCE, is based on a 
signalling pathway requires the activation of p38 MAP Kinase, Serum & 
Glucocorticoid inducible Kinase (SGK1), and Nuclear Factor κB (NFκB). On the other 
hand, the mechanism of action, by which TGFβ1 upregulates Na+/Ca2+ exchangers 
remained unidentified, as well as the specific Na+/Ca2+ exchanger isoforms involved in 
the process of up-regulation. The present study aimed to identify, whether TGFβ1 
influences the expression and activity of K+-independent (NCX) and K+-dependent 
(NCKX) Na+/Ca2+ exchangers, and aimed also to explore the signalling involved. 
Methods: In human megakaryocytic cells (MEG01), Fura-2 fluorescence was 
utilized to observe cytosolic Ca2+ activity [Ca2+]i. The activity of Na+/Ca2+ exchanger 
was studied by observing the rise in [Ca2+]i resulting from changing the extracellular 
solution from a solution with 0 mM Ca2+ and 130 mM Na+ to a solution with 2 mM 
Ca2+ and 0 Na+. For analysis of NCX, the concentration of K+ was 0 mM. For analysis 
of NCKX, the concentration of K+ was 40 mM. In order to quantify transcription levels 
of NCX/NCKX isoform, RT-PCR was applied. 
Results: TGFβ1 (60 ng/ml, 24 h) was found to increase significantly the 
transcription levels of certain isoforms of NCX/NCKX including: NCX1, NCKX1, 
NCKX2 and NCKX5. Additionally, the activity of NCX and NCKX was shown to be 
increased significantly in the presence of TGFβ1 (60 ng/ml, 24 h). Skepinone-L (1 
μM), a p38 MAP Kinase inhibitor, caused a significant downregulation of the effect of 
TGFβ1 on both transcription levels and activity of NCX and NCKX. GSK-650394 (10 
μM), an inhibitor of SGK1, and Wogonin (100 μM), and inhibitor of NFκB, caused a 
significant downregulation of the effect of TGFβ1 on the activity of NCX and NCKX. 
Conclusions: P38 MAP Kinase, SGK1 and NFκB are involved in the signaling 
pathway by which TGFβ1 increases the activity of Na+/Ca2+ exchanger and the 
transcription levels of NCX1, NCKX1, NCKX2, and NCKX5. 
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Zusammenfassung 
 
Der Transforming Growth Factor β1 (TGFβ1) spielt eine wichtige Rolle in der Regulation von 
Megakaryocyten-Reifung und Thrombocyten-Bildung. TGFβ1 steigert sowohl die Speicher-
abhängige Ca2+-Freisetzung [store operated Ca2+ entry (SOCE)] als auch den Ca2+ Export über 
Na+/Ca2+ Austauscher. Somit steigert TGFβ1 sowohl die Zunahme der cytosolische Ca2+ Aktivität 
([Ca2+]i) durch Freisetzung von  Ca2+ aus intracellulären Speichern, als auch die folgende 
Abnahme von [Ca2+]i.  
Die Wirkung von TGFβ1 auf SOCE wird durch einen Signalweg mit p38 MAP Kinase, Serum 
& Glucocorticoid inducible Kinase (SGK1) und Nuclear Factor κB (NFκB) vermittelt. Der 
Signalweg, über den TFβ1 den Na+/Ca2+ Austausch beeinflußt und welcher Na+/Ca2+ Austauscher 
beteiligt ist, blieb unbekannt. Die Doktorarbeit befasst sich mit dem Einfluss von TGFβ1 auf 
Expression und Akitivität von K+-unabhängigen (NCX) und K+-abhängigen (NCKX) Na+/Ca2+ 
Austauschern, sowie mit den beteiligten Signalwegen.  
Methoden: In humanen Megakaryocyten (MEG01) wurde mit Hilfe von Fura-2 Fluoreszenz 
[Ca2+]i gemessen und die Na+/Ca2+ Austauscher Aktivität vom [Ca2+]i Anstieg nach Wechsel von 
einer extrazellulären Lösung mit 130 mM Na+ und 0 mM Ca2+ zu einer extrazellulären Lösung mit 
0 Na+ und 2 mM Ca2+. Die K+ Konzentration war 0 mM zur Analyse von NCX und 40 mM zur 
Analyse von NCKX. RT-PCR wurde zur Quantifizierung der NCX/NCKX Isoform-Transcripte 
eingesetzt.  
Ergebnisse: TGFβ1 (60 ng/ml, 24 h) steigerte significant die Transcription von NCX1, 
NCKX1, NCKX2 und NCKX5. TGFβ1 (60 ng/ml, 24 h) steigerte ferner significant die Aktivität 
sowohl von NCX als auch von NCKX. Die Wirkung von TGFβ1 auf die NCX und NCKX 
Transcription und Aktivität wurde significant durch den p38 Kinasehemmer Skepinone-L (1 μM) 
gehemmt. Die Wirkung von TGFβ1 auf die NCX und NCKX Aktivität wurde durch den SGK1-
Hemmer GSK-650394 (10 μM) und den NFκB-Hemmer Wogonin (100 μM) reduziert.  
Schlussfolgerung: TGFβ1 steigert significant die Transcription von NCX1, NCKX1, NCKX2 
sowie NCKX5 und damit die Na+/Ca2+ exchanger Aktivität, eine Wirkung, die p38 kinase, SGK1 
und NFκB erfordert. 
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1. Introduction 
 
1.1. Calcium in Human Body 
 
Calcium is an important intracellular messenger in the human body and also in all 
living organisms. Calcium is counted as one of the most profuse minerals in the body. 
Many cellular progressions and physiological functions such as the polymerisation of 
fibrin, the transmission of impulses in the nervous system and the function of Skeletal 
muscles are regulated by calcium which plays as well a central structural role in the 
body. One of the essential physiological roles of calcium is its role as an intracellular 
messenger (Bagur and Hajnoczky 2017). 
Hormonal and exocrine secretion and muscular motility as well as motility in 
nonmuscle cells in addition to many other cellular functions are regulated by Calcium 
signalling which plays a significant role in a variety of metabolic pathways (Carafoli 
1988). 
Most of the intracellular Ca2+ is stored in the ER. The release of Ca2+ from 
endoplasmic reticulum (ER) activates specific Ca2+ channels on the plasma membrane 
of the cell, which contributes additionally to the increase of intracellular Ca2+ levels. 
Eventually, the intracellular Ca2+  concentration might pass by (10-100 times) its levels 
in rest mode (Groenendyk, Lynch et al. 2004). 
 
1.2. Calcium Homeostasis and Signalling 
 
Free Ca2+ concentrations can be extensively varied inside different intracellular organelles. 
Some organelles can store Ca2+ and accumulate higher [Ca2+] than the cytoplasm. Those organelles 
are called Ca2+ stores, and among them Calcium can be basically stored in endoplasmic reticulum 
(ER) and, in muscle cells, sarcoplasmic reticulum (SR). However, the concentrations of free 
Ca2+ in other organelles such as the mitochondrial matrix and nuclear matrix are similar to the 
cytoplasmic [Ca2+]. On the other hand, the extracellular milieu has higher levels of [Ca2+] 
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compared to the cytoplasm in resting mode. The cytoplasmic [Ca2+] can be kept lower in resting 
cells by the activity of Na+/Ca2+ exchanger (NCX) and the plasma membrane Ca2+ transport 
ATPase (PMCA) (Bagur and Hajnoczky 2017). 
Cytoplasmic [Ca2+] can be tuned through active and passive mechanisms. The first includes 
Na+/Ca2+ exchangers (NCX), plasma membrane and ER/SR- Ca2+ - ATPases, while Ca2+ channels 
represent the passive mechanism. Both active and passive mechanisms are vital for the cell to keep 
its intracellular Ca2+ concentration levels always in a favorable range for intracellular signalling 
and other cellular activities (Martinez-Zaguilan and Wesson 1996). 
The ER particularly stores the majority of intracellular Ca2+. Ca2+ channels in the plasma 
membrane are activated when ER releases Ca2+, resulting in an intracellular [Ca2+] increase 
between 10-100 fold. (Groenendyk, Lynch et al. 2004) 
Ca2+ homeostasis is vital in the process of aging, heart disease, cancer, and neurodegeneration 
(Squier and Bigelow 2000). 
For instance, a dysregulation of intracellular Ca2+ homeostasis in neurons causes misfunction 
in Ca2+-dependent signalling pathways, can be associated with Brain aging. (Hartmann, Eckert et 
al. 1994) 
 
1.3. Na+/Ca2+ Exchangers 
 
Na+/Ca2+ exchanger molecules in mammalian cells are categorized in two sequenced and 
cloned families (Blaustein and Lederer 1999, Philipson and Nicoll 2000, Shigekawa and Iwamoto 
2001).  
The first family is K+-independent (NCX) exchangers, which has an exchanging ratio of 
1Ca2+:3Na+ (Philipson and Nicoll 2000). NCX exchangers family has 3 isoforms that have been 
identified: NCX1, NCX2, NCX3 (Aneiros, Philipp et al. 2005). 
The second family of Na+/Ca2+ exchangers is K+-dependent (NCKX) exchangers, which has 
an exchanging ratio of (1 Ca2+ +1 K+):4 Na+  (Schnetkamp, Basu et al. 1989). NCKX exchangers 
family has six isoforms (Cai and Lytton 2004) 
NCX1 is generally expressed in every mammalian cell (Kofuji, Lederer et al. 1994, 
Quednau, Nicoll et al. 1997). NCX2 is mainly found in the brain and spinal cord, and can be 
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expressed kidney tissues and the gastrointestinal tract. NCX3 is largely expressed in the skeletal 
muscles and the brain, but it can also be expressed in osseous tissue and the immune system 
(Quednau, Nicoll et al. 1997, Michel, Verkaart et al. 2014, Michel, Hoenderop et al. 2015)   
NCKX1 is predominantly expressed in retinal photoreceptors (Kang and Schnetkamp 2003). 
The expression of NCKX2 is mainly in the brain. NCKX3 is generally expressed mostly in the 
brain, aorta, lung, and intestine. NCKX4 is expressed mainly in the brain (Visser, Valsecchi et al. 
2007). NCKX5 is expressed in melanocytes and seems to play an important role in skin 
pigmentation (Altimimi and Schnetkamp 2007). NCKX6 has a ubiquitous expression in all tissues 
(Cai and Lytton 2004).  
Na+/Ca2+ exchangers can function in both directions: forward mode or reverse mode 
(Philipson, Nicoll et al. 2002). In the forward mode, the activity of the Na+/Ca2+ exchanger results 
in the exclusion of Ca2+ in exchange for Na+ entry, the opposite way is the reverse mode which 
leads to the influx of Ca2+ and the extrusion of Na+. (Philipson, Nicoll et al. 2002, Annunziato, 
Pignataro et al. 2004)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.1. Structure and function of sodium/calcium exchangers (Berridge 2014). 
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What regulates the activity of Na+/Ca2+ exchangers in favor of forward mode (Ca2+-efflux) or 
reverse mode (Ca2+-influx) are the prevailing electrochemical driving forces for Ca2+ and Na+ 
(Armoundas, Hobai et al. 2003). 
Thus, the membrane potential (Baczko, Giles et al. 2003) and the transmembrane gradients of 
Na+  can control how the Na+/Ca2+ exchanger functions (Philipson and Nicoll 2000). The Na+/Ca2+ 
exchanger is driven by transmembrane sodium motive force which can let the exchanger force 
Ca2+ transport even against its concentration gradient (Marinelli, Almagor et al. 2014). In K+-
dependent Na+ / Ca2+  exchangers (NCKX), exchanging Ca2+  requires both the K+ and 
Na+ electrochemical gradients in order to power the extrusion or influx of Ca2+  (Blaustein and 
Lederer 1999) 
For instance, when the intracellular Na+ concentration increases, it sets the exchanger in the 
reverse mode. Na+/Ca2+ exchanger can be shifted into reverse mode and start contributing to the 
influx of Ca2+ even when the alterations in intracellular Na+ concentration and/or membrane 
potential are relatively small (Armoundas, Hobai et al. 2003). 
This increase in intracellular [Ca2+]i which is mediated by Na
+/Ca2+ exchangers can be 
functionally relevant and can be the trigger of some physiological operations in the cell (Paluzzi, 
Alloisio et al. 2007, Reyes, Verkhratsky et al. 2012). 
 
1.4. Calcium in Megakaryocytes 
 
Megakaryocytes descend from hematopoietic stem cells (HSCs), which represent a lifetime 
source of all blood cells in circulation (Ogawa 1993, Pang, Weiss et al. 2005). 
This process of producing different distinct types of blood cells starting from HSCs requires 
a chain of sequential differentiations in which the proliferative and developmental capacities of 
descendant cells become gradually more limited (Pang, Weiss et al. 2005). 
 In normal cases, approximately 1 in each 10,000 nucleated cells in human marrow is 
Megakaryocyte (Branehog, Ridell et al. 1975). 
megakaryocyte is a large cell (∼50–100 μm diameter) with a single, large, polyploid 
nucleus(Pang, Weiss et al. 2005). each megakaryocyte produces about 104 platelets (Long 1998). 
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The production of platelets by megakaryocytes is controlled by a group of environmental and 
autocrine elements (Di Buduo, Moccia et al. 2014). The autocrine factors can be represented 
basically in the release of TGFß1 (Sakamaki, Hirayama et al. 1999, Ponce, de Lourdes F. 
Chauffaille et al. 2012, Badalucco, Di Buduo et al. 2013) and adenosine diphosphate (Di Buduo, 
Moccia et al. 2014) by human megakaryocytes which lead to an increase in cytosolic calcium 
concentration in megakaryocyte itself (Di Buduo, Moccia et al. 2014, Yan, Schmid et al. 2015). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure.2. Megakaryopoiesis pathways. (Pang, Weiss et al. 2005) 
Megakaryocytes descend from hematopoietic stem cells (HSCs), which represent a lifetime source of all blood cells 
in circulation 
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Calcium release from intracellular stores doesn’t only trigger signaling pathways that activates 
megakaryocyte differentiation and proplatelet formations, but it also induces extracellular calcium 
entry which mainly plays important role in the regulation of the contractile force controlling 
megakaryocyte motility (Di Buduo, Moccia et al. 2014).  
Motility is crucial to the formation of platelets as Mks are supposed to migrate during 
differentiation, from the osteoblastic to the vascular niche (Avecilla, Hattori et al. 2004). 
This shows that not only calcium release from intracellular stores (mainly ER) but also 
calcium entry from extracellular milieu into the cell are essential to the regulation of the functions 
of human megakaryocytes (Di Buduo, Moccia et al. 2014). 
A variety of Ca+2 channels have been shown to play functional roles in platelet activation 
(Sun, Li et al. 1998, Mahaut-Smith 2012). In addition to Ca2+ channels, many other ion channels 
have been proved to participate in the regulation of the function of platelets including Kv1.3 
voltage gated channels, P2X1 ATP-gated  channels, connexin gap junction channels and kainate 
glutamate receptors (Mahaut-Smith 2012). 
 
1.5. Transforming Growth Factor ß1 (TGFß1) 
 
TGFß1 is a member of the transforming growth factor TGF-β superfamily. This multipotent 
cytokine superfamily has important roles in regulating a wide range of cellular pathways and 
functions.(Hwangbo, Tae et al. 2016)  
TGFß1 is expressed in a broad variety of the body tissues including largely expression in 
spleen, bone marrow and 23 other tissues. (Fagerberg, Hallstrom et al. 2014) 
 
1.5.1.  The Role of TGFß1 
 
TGF-β1 regulates cellular functions by binding to heteromeric complexes of TGF-β 
receptors which includes two types: TGF-β type I receptor (TβRI) and TGF-β type II receptor 
(TβRII). (Attisano and Wrana 2002).  By binding to its TβR receptors TGF-β activates them. 
Activated TβR in turn initiate the phosphorylation of SMAD2 and SMAD3, which are both 
coupled to the receptor. The phosphorylation of SMAD2 and SMAD3 leads to the formation of 
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strong combinations with SMAD4. Those complexes go then through a translocation to the 
nucleus, where the targeted genes are located.  Once the SMAD complexes are translocated to 
the nucleus they start regulating the transcription of those genes (Zavadil and Bottinger 2005, 
Bierie and Moses 2006). Beside SMAD pathway, TGF-β1 can also activate a variety of other 
signaling pathways including mitogen-activated protein kinase, c-Jun-N-terminal kinase, the 
phosphoinositide 3-kinase/Akt pathways and p38 kinase pathway. (Zavadil and Bottinger 2005, 
Zhang 2009). 
Transforming growth factor ß1 (TGFß1) is described as a multifunctional protein controlling 
a variety of functions including differentiation and proliferation in different cell types. TGFß1 is 
produced and released by many cells and those cells have specific receptors for TGFß1. (Chen, 
Lee et al. 2014) 
Megakaryocytes are one of those cells. TGFβ1 is produced and released by megakaryocytes 
(Bock, Loch et al. 2005, Ponce, de Lourdes et al. 2012, Badalucco, Di Buduo et al. 2013) . TGFβ1 
then binds to its receptors on the membrane of Mks and thus triggers signalling downstreams, and 
so TGFβ1 can be considered an autocrine regulator of megakaryocytes. The resulting effect of 
TGFβ1 on Mks includes the activation of differentiation and eventually the formation of 
proplatelets. (Sakamaki, Hirayama et al. 1999, Badalucco, Di Buduo et al. 2013). Besides its role 
in Mk maturation and platelet formation, TGFβ1 is found to play the major role in stimulating the 
expression of bone marrow stromal thrombopoietin. Thrombopoietin itself plays a role in the 
activation of the expression of TGF-beta receptors in Megakaryocytes, which means that TGF-
beta1 plays also a role as a feedback regulator of megakaryopoiesis. (Sakamaki, Hirayama et al. 
1999).  
TGFβ1 can also control the cytosolic Ca2+ activity [Ca2+]i in megakaryocytes and 
platelets, by its ability to up-regulate the expression of serum/glucocorticoid inducible 
kinase (SGK1), which is a novel regulator of [Ca2+]i in megakaryocytes and platelets. 
The up-regulation of (SGK1) through TGFβ1 pathway occurs through the activation of 
P38 MAPK. (Yan, Schmid et al. 2015). 
The highest concentration of TGFß in the body is found in platelets, and the largest amount 
of TGFß is produced in bones with a concentration of 200 micrograms of TGFß in each 1kg of 
bone tissue. (Bonewald and Mundy 1990). 
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The mechanism of action of TGFß1 activity includes the regulation (positively and negatively) 
of a variety of other growth factors. For instance, TGFß1 has a significant role in bone remodeling 
as it is an effective motivator of osteoblastic bone formation, leading to proliferation or 
differentiation in osteoblasts. (Chen, Lee et al. 2014). TGF-beta can play different roles in bone 
cells based on their phenotype and phase of differentiation.(Bonewald and Mundy 1990). TGFß1 
acts also as a potent stimulator of the sustained synthesize and secretion of collagen in fibroblasts. 
(Sakamaki, Hirayama et al. 1999, Chen, Lee et al. 2014). By activating the differentiation of 
fibroblasts to myofibroblasts which is more effective than the former in producing collagen. 
(Sakamaki, Hirayama et al. 1999). 
 
1.5.2. Deficiency of TGFß1 
 
The occurrence of mutations affecting the gene encoding TGFß1 is responsible for a case 
known as “Camurati-Engelmann disease (CAEND)” 
This disease is an autosomal dominant disorder with symptoms including sclerosis and 
hyperostosis in the diaphysis of long bones. The symptoms can be noticed starting from early 
childhood including muscular weakness, pain, and myopathic gait, and in some cases the 
symptoms can also include difficulties in hearing, paralysis of facial muscles, or eye disorders 
including exophthalmos or vision loss. (Kinoshita, Saito et al. 2000, Janssens, ten Dijke et al. 2003, 
McGowan, MacPherson et al. 2003) 
 
1.6. Serum & Glucocorticoid Inducible Kinase 1 (SGK1) 
 
Serum- and glucocorticoid-inducible kinases (SGKs) are members of the AGC family (protein 
kinase A, G, C families: PKA-, PKG-, PKC-related) of serine/threonine kinases, which can be 
found in most of the cells (Arencibia, Pastor-Flores et al. 2013). 
SGK is remarkably expressed in the liver and contributes to the regulation of cell survival in 
response to environmental changes and stress stimulators (Leong, Maiyar et al. 2003). 
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Other members of the AGC family are AKT (protein kinase B) and PKC (protein kinase C) 
and others. SGK kinases have highest proportion of homology with the AKT family (Firestone, 
Giampaolo et al. 2003, Pearce, Komander et al. 2010). 
The SGK family includes three isoforms (SGK1, SGK2, and SGK3) that are encoded by three 
different genes found on different chromosomes, but those isoform still have high structural 
similarity (Lang and Cohen 2001). 
 
1.6.1. The Role of SGK1 
 
SGK1 is an important regulator of cytosolic Ca2+ and plays an important role in the regulation 
of megakaryocytes maturation and platelets functions. (Borst, Schmidt et al. 2012) 
SGK was initially considered to be under intense transcriptional regulation by glucocorticoids 
and serum (Webster, Goya et al. 1993), but later, SGK has been reported to be controlled by a 
variety of regulators including hormones, growth factors and oxidative and osmotic stress (Buse, 
Tran et al. 1999, Bell, Leong et al. 2000, Mizuno and Nishida 2001, Leong, Maiyar et al. 2003). 
The function of SGK can be regulated at different levels in the cell including transcriptional 
level, subcellular translocation and regulation of enzymatic activity. (Meng, Yamagiwa et al. 2005) 
Several hormones and other factors involve in the regulation of SGK1 including thrombin, 
ischemia, oxidative stress, transforming growth factor TGF-β and other growth factors such as 
IGF-1. (Borst, Schmidt et al. 2012) 
The mechanism of transcription of SGK1 is regulated by a wide range of elements including 
nuclear factor KappaB (NFκB), and SMAD3 and SMAD4 complexes which are transcription 
factors regulated by TGFβ. The regulation of transcription of SGK1 includes also receptors for 
progesterone, mineralocorticoid, glucocorticoid and other factors. (Lang, Artunc et al. 2009) 
SGK1 regulates a variety of transporters, enzymes, ion channels such as ENaC (Faletti, 
Perrotti et al. 2002), and transcription factors such as nuclear factor kappa B NFκB. (Lang, Bohmer 
et al. 2006). SGK1 plays a role also in different cellular functions including the regulation of 
neuroexcitability, hormone release, cell proliferation and apoptosis. (Lang, Bohmer et al. 2006) 
The effects of SGK1 on platelets include the stimulation of coagulation, through tissue factor 
expression (Lang, Artunc et al. 2009) and SGK1 can, by up-regulating NFκB, contribute to the 
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development of strokes (Dahlberg, Smith et al. 2011) and thrombosis (Borst, Schmidt et al. 2012), 
through the NFκB-induced up-regulation of expression of Ca+2 channels such as Orai1/STIM1 in 
the platelets. (Dahlberg, Smith et al. 2011, Borst, Schmidt et al. 2012) 
 
1.6.2. GSK-650394 (SGK1 Inhibitor) 
 
GSK-650394 has higher selectivity for SGK1 compared to that for Akt, which has the highest 
homology to SGK1 among AGC kinase family. GSK-650394 is rather non-toxic. For example, the 
LC50 values are 68 times higher than its IC50 in HeLa cells. The selectivity of GSK-650394 for 
SGK1 was shown to be more than 30 times higher when compared to that for Akt, while compared 
to PDK1 (another AGC kinase family member) the selectivity of GSK-650394 for SGK1 was 60 
times higher (Sherk, Frigo et al. 2008). 
 
1.7. Nuclear Factor kappa B (NFκB) 
 
Nuclear factor KappaB (NFκB) is a cytokine-regulated transcription factor that has an 
important role in the regulation of transcription of genes responsible basically for cell survival and 
inflammation (Ghosh, May et al. 1998). 
NFκB is a protein complex that can regulate gene expression by binding to κB sites in the 
promoters/enhancers of the targeted genes. NFκB can either activate or suppress the expression of 
genes (Hoffmann and Baltimore 2006).  
In addition to the fact that NFκB is expressed in nearly all cells, it has been found also that κB 
sites, which are the NFκB binding sites on the DNA sequences, exist in the promoters/enhancers 
of a broad variety of genes (Oeckinghaus and Ghosh 2009). 
It is estimated that there are approximately 106 κB sites for NFκB to bind in the human 
genome, and about 500 genes are regulated by NFκB (Natoli, Saccani et al. 2005, Antonaki, 
Demetriades et al. 2011).     
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1.7.1.   The Role of NFκB 
 
NFκB was initially considered a transcriptional activator (Seto 2003), but a variety of studies 
emerged later suggesting and reporting the transcriptional repression activity of NFκB also 
(Ashburner, Westerheide et al. 2001, Baetz, Regula et al. 2005).  
In mammalians, five NFκB family members are discovered: RelA (p65), RelB, c-Rel, 
p50/p105 (NFκB1) and p52/p100 (NFκB2) (Tieri, Termanini et al. 2012) 
However, 12 distinct dimers can be formed out of those five members through their ability to 
homo- or hetero-dimerise (Christian, Smith et al. 2016). 
The available data demonstrate that nuclear factor-κB (NFκB) consists of a group of 
transcription factors that have major roles in cellular responses in a variety of aspects including 
inflammation, immunity, cell survival, differentiation, and proliferation (Oeckinghaus and Ghosh 
2009). 
NFκB is found in its inactive mode in the cytoplasm of the cell (Sheppard, Rose et al. 1999). 
Being in its inactive mode is caused by binding to inhibitory proteins, such as IκB-α. The activation 
of NFκB requires phosphorylation of the inhibitory protein. This phosphorylation is accomplished 
by an IκB kinase complex (IKK) leading to the degradation of the inhibitory protein. The activation 
of NFκB, by the phosphorylation of as IκB, acts as a trigger for NFκB dimer to be translocated to 
the nucleus, where it starts the regulation of expression of specific genes (Maniatis 1997, Sheppard, 
Rose et al. 1999). 
As NFκB has the ability to regulate the expression of a wide range of genes, thus the activity 
of NFκB is firmly regulated and fine-tuned at different levels in the cell. The first step in the 
process of regulation of NFκB activity is represented by the inhibitory proteins (IκBs) and the 
(IKK) kinase complex phosphorylating the (IκB) (Oeckinghaus and Ghosh 2009). 
SGK1 can regulate the activation of NFκB, as SGK1 has the ability to phosphorylates the IκB 
kinase complex (IKK), which is responsible for phosphorylation of the inhibitory protein IκB-
α what leads eventually to translocation of nuclear factor NFκB to the nuclear (Yan, Schmid et al. 
2015). 
The transcriptional activity of NFκB is regulated also by p38 MAP kinase. The regulation of 
NFκB, which takes place at the nuclear level, is unrelated to the translocation of transcription 
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factor to its site in the nucleus and independent from the potency of the transcription factor to 
attach to the targeted genes. P38 MAP kinase was found to regulate the phosphorylation of NFκB 
ReIA in RAW264.7 cells (Olson, Hedrick et al. 2007).  
In general, the activity of NFκB is regulated through a variety of mechanisms including post-
translational modifications such as acetylation or phosphorylation of NFκB (Hayden and Ghosh 
2004, Xiao 2004). 
As NFκB regulates a variety of essential cellular physiological activities including 
proliferation, immunity and cell survival, so in cases of malfunction of the regulation of NFκB 
activity, the outcomes are represented in severe disorders and diseases including 
immunodeficiency, autoimmunity, arthritis and cancer (Courtois and Gilmore 2006). 
In Megakaryocytes, NFκB is crucial to the regulation of megakaryocytopoiesis. Up-regulation 
of the activity of p38 MAPK in megakaryocytes leads to up-regulation of the activity of NFκB 
which enhances maturation of megakaryocytes and thus platelet production (Wu, Xie et al. 2015). 
 
1.7.2.    Wogonin (NFκB inhibitor) 
 
Wogonin (5,7-dihydroxy-8-methoxyflavone) is an effective NFκB pathway inhibitor (Wu, 
Xie et al. 2015). It is extracted from Scutellaria baicalensis Georgi (known also as Huang-Qin) 
(Xu, Yang et al. 2016). Wogonin plays a role in several medical cases including inflammatory 
diseases, neurological diseases (Lin 2011), allergy (Lucas, Dorward et al. 2015) and tumors 
(Chirumbolo 2013).  
The mechanism by which Wogonin inhibits NFκB is based on a characteristic of NFκB that 
it can be regulated by the redox potential in the cell (Pantano, Reynaert et al. 2006). In cases of 
oxidative stress, elevated intracellular levels of reactive oxygen species (ROS) causes the 
activation of NFκB (Fas, Baumann et al. 2006).  
Wogonin has an effect on the cellular redox homeostasis. It causes an alteration in the redox 
state of the cell towards less oxidative state (H202), by scavenging oxidative radicals (O2-). 
Through this mechanism Wogonin can cause the ROS-mediated NFκB activation to be down-
regulated.(Fas, Baumann et al. 2006, Li-Weber 2009)  
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1.8. P38 Mitogen-Activated Protein Kinase (p38 MAPK) Pathway 
 
1.8.1.  The Role of p38 Kinase 
 
p38 MAP kinase is a stimulator of transcription factors through phosphorylation. Its activity 
involves the activation of nuclear kinases among other kinases also (Deak, Clifton et al. 1998). 
Similar to SGK1, the p38 MAP kinase functions in response to environmental stimulators. 
P38 MAPK has an important role in the regulation of those intracellular responses. The activation 
of p38 MAPK pathway can be triggered by external elements and environmental stress, such as: 
UV radiation, heat shock, proinflammatory cytokines, bacterial lipopolysaccharide (LPS) or 
hormones (Meng, Yamagiwa et al. 2005). A variety of downstream signaling intracellular 
responses result from the activation of p38 MAPK. Those cellular responses include apoptosis, 
differentiation, cell cycle regulation, inflammatory responses (Nebreda and Porras 2000). 
In general, the regulatory effect of P38 for certain stimuli depends on two factors including 
cell type and the condition of the cell (Conde, Pabon et al. 2010). 
As a result of variation of those two factors, different responses for p38 activity can be 
observed. p38 MAPK can induce differentiation (Yosimichi, Nakanishi et al. 2001), apoptosis 
(Wang, Li et al. 2005) or cell survival through inhibition of apoptosis (Zhang, Shan et al. 2003). 
The p38 MAPK family includes four major isoforms: p38α (MAPK14), p38β (MAPK11), 
p38γ (MAPK12), and p38δ (MAPK13). These isoforms are encoded by different genes and 
expressed in different tissues. However, under situations of extracellular changes the p38 MAPKs 
act in correspondence in order to produce intracellular signaling complexes resulting in specific 
reactions in correspondence to each external stimulation (Bachstetter and Van Eldik 2010). In 
cases of p38 activation in response to inflammatory stimulation, the process of activation includes 
phosphorylation of two residues in p38, which are Thr and Tyr. This activation of p38 is 
accomplished by upstream kinases, and the activated p38 in turn activates downstream pathways 
by phosphorylating specific substrates which ends up eventually in the upregulation of 
proinflammatory cytokines production (Schieven 2009). 
P38 MAPK can regulate Serum and Glucocorticoid-inducible Kinase (SGK). The regulation 
can take place through more than one possible mechanism. it can occur at the transcriptional level 
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or by phosphorylating the Ser78 residue of SGK. Even p38 MAPK activity in its constitutive level 
can regulate SGK (Meng, Yamagiwa et al. 2005). 
Inhibitors of p38 MAPK block the phosphorylation of SGK at Ser78 and thus inhibits the 
activation of SGK. On the contrary, when the expression of p38 MAPK is up-regulated it results 
in the augmentation of the constitutive phosphorylation and thus the constitutive activity of SGK 
(Meng, Yamagiwa et al. 2005). 
In Megakaryocytes it is suggested that the downregulation of P38 MAPK has a major effect 
on the differentiation of Megakaryocytes (Jacquel, Herrant et al. 2006).  
P38 plays a key role in regulating the progress of the differentiation and the final phenotype 
in Megakaryocytes (Conde, Pabon et al. 2010). 
P38 is suggested also to have an important effect on the progress of cell cycle through negative 
regulation (Bulavin and Fornace 2004, Hui, Bakiri et al. 2007). 
In general, p38 MAPKs pathway is involved in Megakaryocyte differentiation along with 
ERK1/2 and PI3K pathways. The available data show that p38 MAPK plays a key role in the 
regulation of megakaryocytopoiesis. (Conde, Pabon et al. 2010).  
 
1.8.2.   Skepinone-L, a selective P38 Kinase Inhibitor 
 
Skepinone-L, which is a dibenzosuberone compound, is a p38 MAPK inhibitor 
with a high in vivo potency and a superior selectivity compared to the majority of other 
p38 inhibitors (Koeberle, Romir et al. 2011). 
Most of other p38 MAPK inhibitors have a molecular weight >500 Da., which 
makes them considered large molecules, a characteristic that counts unfavourable for in 
vivo efficacy. In comparable whole-blood assays, the majority of p38 MAPK inhibitors 
are found to have moderate potency (Goldstein and Gabriel 2005) which demands 
higher in vivo plasma concentration in order to reach the required inhibitory effect. 
Many p38 MAPK inhibitors are ATP-competitive inhibitors, which is considered 
relatively a weakness point in the domain of selectivity as the ATP-site retains 
unchanged a wide range of proteins, and thus most of the p38 MAPK inhibitors, 
including (SB203580) and (BIRB796), have poor selectivity. Skepinone-L has two 
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features in its structure that grant the outstanding selectivity for p38 MAPK. Those two 
features are represented in the L-glycine–flip at Gly110 and the linear binding ability. 
Beside its selectivity, Skepinone-L has high in vivo potency which ensures the ability 
of having a clear-cut examining of the p38 MAPK signalling pathway (Koeberle, 
Romir et al. 2011). 
 
1.9. AIM OF THE STUDY 
 
The aim of the present study was to investigate whether p38 MAPK, NFκB and 
SGK1 can up-regulate Na+/Ca2+ exchanger in Megakaryocytes following treatment 
with TGFß1. 
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2. MATERIALS AND METHODS 
 
2.1.   Materials 
 
2.1.1.   Culture of Megakaryocytes 
 
Equipments 
Name      Manufacturer and country of origin 
Heraeus Incubator    Thermo Electron Corporation, Dreieich, Deutschland 
Cell culture flask    Darstedt AG, Nümbrecht, Deutschland 
Centrifuge RotoFix 32    Hettich Zentrifugen, Tuttlingen, Deutschland 
Eppendorf pipettes 10, 100, 1000 µL  Eppendorf AG, Hamburg, Deutschland 
6-well plates     BD Biosciences, Franklin Lakes, NJ, USA 
Eppendorf cups 1.5 mL    Eppendorf AG, Hamburg, Deutschland 
Neubauer counting chamber   Brand, Wertheim, Deutschland 
Vortex Genie     Scientific Industries, Bohemia NY, USA 
 
Chemicals 
Name      Manufacturer and country of origin 
RPMI-1640     Gibco, Carlsbad, Deutschland 
FBS (Fetal bovine serum)   Gibco, Carlsbad, Deutschland 
Penicillin/streptomycin    Gibco, Carlsbad, Deutschland 
PBS (Phosphate buffered saline)  Gibco, Carlsbad, Deutschland 
TGFß1      Sigma, Taufkirchen, Deutschland 
Skepinone-L     Merck, Darmstadt, Deutschland 
GSK-650394     Tocris, Wiesbaden-Nordenstadt, Deutschland 
Wogonin     Sigma, Darmstadt, Deutschland 
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2.1.2.   Intracellular Calcium Imaging 
 
• Equipments for calcium measurment 
Name       Company    
Camera Proxitronic     Proxitronic, Bensheim, Deutschland 
Centrifuge RotoFix 32     Hettich Zentifugen, Tuttlingen, Deutschland 
Cover glasses round, 30mm, Thickness No. 1  VWR, Darmstadt, Deutschland 
Discofix® Stopcock for Infusion Therapy  B.Braun, Melsungen AG (global), Deutschland 
Eppendorf pipettes 1000 µL, 100 µL, 10 µL  Eppendorf AG, Hamburg, Deutschland 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 3. Calcium measurement equipments 
1. Shutter instrument, 2. Camera, 3. control panel of the Camera, 4. Microscope, 5. Cell chamber, 
6. Warming system of Extracellular solutions, 7. Transmission system of extracellular solutions, 8. Control panel of 
xenon lamp, 9. Control panel of Light.  
1 
2 
3 
4 
5 
6 
7 
8 
9 
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Eppendorf cups 1.5, 2 mL    Eppendorf AG, Hamburg, Deutschland 
Filter tips 10, 100, 1000 µL    Biozym Scie., Hess.Oldendorf, Deutschland 
Filter wheel      Sutter Inst. Co., Novato, USA 
Incubator Thermo Electro. Cor., Dreieich, Deutschland 
Lamp XBO 75      Leistungselektronik GmbH, Jena, Deutschland 
Metafluor Software     Universal Imaging, Downingtown, USA 
Microscope Axiovert 100    Zeiss, Oberkochen, Deutschland 
Multiwell™ 6 well Becton Dichinson Labware, Franklin Lakes, 
USA 
Needles BD Microlance™3, 1.2X40mm Becton Dichinson Labware, Franklin Lakes, 
USA 
Objective neo fluar 40X/1.3 oil    Carl Zeiss, Oberkochen, Deutschland 
Syringe BD 10ml. Luer-Lok™ Tip   Becton Dichinson labware, Franklin Lakes, USA 
Syringe BD, Perfusion™ 50 mL    Becton Dichinson labware, Franklin Lakes, USA 
 
• Calcium Measurement Chemicals 
Name       Company    
Fura-2 AM      Invitrogen, Göttingen, Deutschland 
Thapsigargin      Invitrogen, Karlsruhe, Deutschland 
Poly-L-lysine Sigma-Aldrich Chemie GmbH, Munich, 
Deutschland 
Immersol 518F     Carl Zeiss, Göttingen, Deutschland 
Silicone Gel      Carl Roth, Karlsruhe, Deutschland 
NaCl       Sigma, Taufkrchen, Deutschland 
KCl       Carl Roth, Karlsruhe, Deutschland 
TAE+ (Tetraethylammonium-chloride-Monohydrat) Sigma, Taufkirchen, Deutschland 
HEPES      Sigma, Taufkirchen, Deutschland 
Glucose      Carl Roth, Karlsruhe, Deutschland 
NMDG (N-Methyl-D-glucamine)   Sigma, Taufkirchen, Deutschland 
CaCl2.2H2O      Carl Roth, Karlsruhe, Deutschland 
MgCl2.6H2O      Sigma, Taufkirchen, Deutschland 
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• Calcium measurement Buffer Composition 
 
Table.1. Standard Extracellular Solution with 0mM KCl (for NCX)  
Substance   concentration  
NaCl     130 mM 
KCl       0 mM 
MgCl2.6H2O       2 mM 
HEPES     10 mM 
Glucose      5 mM 
H2O (370C), pH 7.4 (NaOH) 
 
Table.2. ONa+-Extracellular Solution with 0mM KCl (for NCX) 
Substance   Concentration 
NMDG    90 mM 
KCl      0 mM 
CaCl2.2H2O     2 mM 
MgCl2.6H2O     2 mM 
HEPES    10 mM 
Glucose     5 mM 
H2O (370C), pH 7.4 (HCl) 
Table.3. Standard Extracellular Solution with 40mM KCl (for NCKX)  
Substance   Concentration 
NaCl     130 mM 
KCl      40 mM 
TAE+      20 mM 
MgCl2.6H2O       2 mM 
HEPES     10 mM 
Glucose      5 mM 
H2O (370C), pH 7.4 (NaOH) 
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Table.4. ONa+-Extracellular Solution with 40mM KCl (for NCKX)  
Substance   Concentration 
NMDG    90 mM 
KCl     40 mM 
TAE+     20 mM 
CaCl2.2H2O      2 mM 
MgCl2.6H2O      2 mM 
HEPES    10 mM 
Glucose     5 mM 
H2O (370C), pH 7.4 (HCl)  
 
2.1.3.   Real Time PCR 
 
Technical Equipment 
Equipment     Company      
Densitometer     BioRad, München, Deutschland 
Low Profile 96 Well PCR Plates PEQLAB Biotechnologie GMBH; Erlangen, 
Deutschland 
CFX96 Real Time System   BioRad, München, Deutschland 
PCR Plate Sealing films / Foils  Biozym Biotch Trading GMBH 
 
Chemicals 
Product     Company      
Chloroform     Carl Roth, Karlsruhe, Deutschland 
DEPC Water     Promega, Mannheim, Deutschland 
dNTP mix      Promega, Mannheim, Deutschland 
Ethanol 99.7%    VWR, Darmstadt, Deutschland 
2 X GoTaq®qPCR Master Mix  Promega, Hilden, Deutschland 
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PeqGOLD TriFast Peqlab Biotechnologi GMBH, Erlangen, 
Deutschland 
Primers      Invitrogen, Darmstadt, Deutschland 
Transcriptor High Fidelity cDNA Synthsis Kit Roche Diagnostics, Penzberg, Deutschland 
2-Propanol (Isopropanol)    Sigma, Taufkirchen, Deutschland 
 
Primers 
Name       Company     
NCX1, NCX3, NCKX1, NCKX2, NCKX5, 
NCKX6, GAPDH   Invitrogen, Darmstadt, Deutschland 
 
2.2. Methods 
 
2.2.1. Culture of Megakaryocytes 
 
The source of Megakaryocytes (MEG-01) was the American Type Culture collection (ATCC). 
Human Megakaryocytes MEG-01 (ATCC® CRL-2021™) were cultured in cell culture flask. The 
medium was changed every third day. An RPMI-1640 (Roswell Park Memorial Institute) medium 
(Gibco, Carlsbad, Deutschland) containing 1% Penicillin/Streptomycin and 10% Fetal Bovin 
Serum (FBS) (Gibco, Carlsbad, Deutschland) was used. The cells were cultured in humidified 
atmosphere at 37°C with a consistent 5% CO2.  
For experiments, Meg-01 cells were moved into 6-well plates (BD Biosciences, Franklin 
Lakes, NJ, USA) at a density of 2 × 105 cells/well. 
In the first stage of the experiment, Concentration dependence and time dependence of TGFβ-
stimulated Na+/Ca2+ exchanger activity in megakaryocytes were detected. In order to detect the 
concentration dependence, the Meg-01 cells were categorized into a control group and other three 
groups. Untreated cells were used as controls. The other three groups were treated with 20, 40 or 
60 ng/ml of TGFß1 (Sigma, Taufkirchen, Deutschland) for 24 hours. Then, the TGFß1 
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concentration of 60 ng/ml was adopted for next step of the experiment, as it showed significant 
upregulation of the activity of Na+/Ca2+ exchangers after 24 hours. 
In order to detect the time dependence of TGFβ-stimulated Na+/Ca2+ exchanger activity in 
megakaryocytes for 60 ng/ml of TGFβ1, the Meg-01 cells were categorized into a control group 
and other three groups. Untreated cells were used as controls. The other three groups were treated 
with 60 ng/ml of TGFß1 for 6, 12 or 24 hours. 
Treatment of Meg-01 cells with 60 ng/ml of TGFβ1 for 24 hours was adopted for the next 
stage of the experiment. 
In the second stage of the experiment, the role of p38 kinase, SGK1 and NFκB in the 
regulation of the TGFß-induced activity and expression of Na+/Ca2+ exchangers were detected. 
In order to detect the role of p38 kinase, Meg-01 cells were distributed into three groups. The 
first group was treated with 60 ng/ml of TGFß1 for 24 hours. The second group was treated with 
60 ng/ml of TGFß1 and p38 kinase inhibitor, Skepinone-L (1 μM, Merck) for 24 hours. Untreated 
Meg-01 cells were used as a control group. 
The role of SGK1 was detected through making three groups of Meg-01 cells. The first group 
was treated with 60 ng/ml of TGFß1 for 24 hours. The second group was treated with 60 ng/ml of 
TGFß1 and SGK1 inhibitor, GSK-650394 (10 μM, Tocris) for 24 hours. Untreated Meg-01 cells 
were used as controls. 
In order to detect the role of NFκB, Meg-01 cells were categorized into three groups. The first 
group was treated with 60 ng/ml of TGFß1 for 24 hours. The second group was treated with 60 
ng/ml of TGFß1 and NFκB inhibitor, Wogonin (100 μM, Sigma) for 24 hours. Untreated Meg-01 
cells were used as a control group. 
  
2.2.2. Measurement of Intracellular Calcium 
 
The utilization of Fura-2 fluorescent dye was required in order to determine the intracellular 
Ca+2 activity. The Meg01 cells were loaded with Fura-2/AM (2 μM, Invitrogen, Goettingen, 
Deutschland) and Thapsigargin (1 µM, Invitrogen) for 20-60 minutes at 37 °C. 
At wavelengths of 340 nm and 380 nm alternatively the cells were excited through a 
fluorescence microscope (Axiovert 100, Zeiss, Oberkochen, Deutschland). A dichroic mirror 
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deflected the light either to an objective (Fluor 40×/1.30 oil) or to a camera (Proxitronic, Bensheim, 
Deutschland). At a wavelength of 505 nm the emitted fluorescence intensity was recorded. A 
specialized computer software (Metafluor, Universal Imaging, Downingtown, USA) was used to 
acquire the data.  
The removal of extracellular sodium would cause the cytosolic Ca+2 of the cell to be changed 
through the activity of Na+/Ca+2 exchanger which gives the ability to estimate this activity using 
the calcium imaging technique. In order to achieve the removal of extracellular Sodium, two 
solutions are required. The first solution is a Standard Ringer containing Na+ and the second 
solution is a ONa+-Ringer Solution. In case of measuring the activity of potassium-dependent 
NCKX, both solutions should be also containing potassium K+; but in case of measuring the 
activity of NCX both solutions should be 0 K+. 
In order to perform the experiment, the extracellular standard Na+-containing solution was 
replaced by 0 Na+-solution. 
The standard ringer solution required to determine the activity of NCX is composed of (in 
mM): 130 NaCl, 0 KCl, 2 MgCl2, 10 HEPES, 5 Glucose, pH 7.4. The Sodium-free ringer solution 
for NCX is composed of (in mM): 90 NMDG, 0 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 5 Glucose, 
pH 7.4. 
In order to determine the activity of Potassium dependent Sodium/Calcium Exchanger NCKX, 
Na+-containing standard ringer solution is required and it is composed of (in mM): 130 NaCl, 40 
KCl, 20 TAE+, 2 MgSO4, 10 HEPES, 5 Glucose, pH 7.4 whereas the Na
+-free ringer solution is 
composed of (in mM): 90 NMDG, 40 KCl, 20 TAE+, 2 CaCl2, 2 MgCl2, 10 HEPES, 5 Glucose, 
pH 7.4. 
For quantification of Ca+2 entry, the peak (delta ratio) and slope (delta ratio/s) were calculated 
subsequent to the removal of Na+. 
 
2.2.3.  Real-Time PCR 
 
The extraction of total RNA from MEG01 cells was carried out by TriFast (Peqlab, Erlangen, 
Deutschland) in correspondence to the procedures mentioned in the manufacturer’s protocol. 
DNAse digestion was performed and then it was followed by a reverse transcription of total RNA 
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using Transcriptor High Fidelity cDNA Synthesis Kit (Roche Diagnostics, Penzberg, 
Deutschland). RT-PCR of the targeted sequences were constructed in a total volume of 20 μl using 
40 ng of cDNA, 500 nM forward and reverse primer and 2x GoTaq® qPCR Master Mix (Promega, 
Hilden, Deutschland). The procedures were performed based on the manufacturer's instructions. 
For efficient amplification Cycling parameters were set as following: initial denaturation step was 
carried out at 95°C for 5 min, then 40 cycles of 95°C for 15 sec, 58°C for 15 sec and 68°C for 20 
sec. The primers used for amplification were as following (5`->3`orientation): 
 
for NCX1:  
fw: ACAAGAGGTATCGAGCTGGC  
rev: ATGCCATTTCTCGCCTAGC  
 
for NCX3:  
fw: GCATTGCCAGGGTCATTGTCT 
rev: CCATAAGGGTCAGGTTGGAGA 
 
for NCKX1:  
fw: TCCACGCAGAAGATGGTG  
rev: GTGATGGAGGGGATAGCG  
 
for NCKX2:  
fw: GAGACAGATACACAGAGCACAGG  
rev: GAGAATAGTACAGATCACGCCC  
 
for NCKX5:  
fw: CTCCATCATCGGAGTTTCC  
rev: CTTCCTACCCTCCCTGGAA  
 
for NCKX6:  
fw: CGTGCTGGTTACCACAGTGG  
rev: CTTCCGTGGCAGGGTCAG  
 
for GAPDH:  
fw: TGAGTACGTCGTGGAGTCCAC  
rev: GTGCTAAGCAGTTGGTGGTG 
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Melt curve analysis was performed to assess the specificity of PCR products. 
CFX96 Real-Time System (Bio-Rad) was utilized to perform the Real-time PCR 
amplifications. All the experiments were performed in duplicate. GAPDH (Glyceraldehyd-3-
phosphate-Dehydrogenase) was used as a reference gene; the amplification of this house-keeping 
gene served thus in the standardization of the amount of sample RNA. The previously described 
ΔCT method was used to carry out relative quantification of gene expression. 
 
2.3. Statistical Analysis 
 
By using paired or unpaired Student t-test and one-way ANOVA (Analysis of variance 
between groups), relative differences between results were tested for significance. 
Data were provided as means ± SEM (standard error of the mean), n represents the number of 
independent experiments. 
P<0.05 was considered statistically significant. 
§/*(p<0.05), §§/**(p<0.01) or §§§/***(p<0.001) 
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3. RESULTS 
  
The aim of the present study was to explore the process by which the upregulation of 
Na+/Ca+2 exchangers by TGFß1 is carried out. 
 
3.1. Determining Concentration and Time Course for TGFβ1-Stimulated 
Na+/Ca2+ Exchanger Activity in Megakaryocytes 
 
In the first step of the experiment, the concentration dependence of TGFβ-stimulated 
Na+/Ca+2 exchanger activity in megakaryocytes was detected, which required comparing the 
cytosolic Ca+2 activity ([Ca+2]i) of untreated control MEG01 cells with other groups of MEG01 
cells treated with different concentration of TGFß1, including: 20 ,40 or 60 ng/ml TGFß1. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 3. TGFß1-induced Ca+2 entry mediated by NCX in megakaryocytes. (Al-Maghout, Pelzl et al. 2017) 
 A. Representative original tracings illustrating intracellular Ca+2 concentrations in megakaryocytes loaded in Fura-2/ 
AM for 20-60 minutes with and without a pretreatment of 20, 40 or 60 ng/ml TGFß1 for 24 hours before and after the 
removal of external Na+ (0 Na+) and adding 2 mM Ca+2 at 0 mM K+. 
B. C. Arithmetic means (± SEM, n = 46 - 59 cells) of the peak (B) and slope (C) of the change in intracellular Ca+2 
concentrations following removal of external Na+ (0 Na+) and adding 2 mM Ca+2 at 0 mM K+ in megakaryocytes with 
and without a pretreatment of 20, 40 or 60 ng/ml TGFß1 for 24 hours. ** (p<0.01), *** (p<0.001) refer to a statistically 
significant difference from untreated control group of megakaryocytes (ANOVA). (Al-Maghout, Pelzl et al. 2017) 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 4. TGFß1-induced Ca2+ entry mediated by NCKX in megakaryocytes. (Al-Maghout, Pelzl et al. 2017) 
A. Representative original tracings illustrating intracellular Ca2+ concentrations in megakaryocytes loaded in Fura-2/ 
AM for 20-60 minutes with and without a pretreatment of 20, 40 or 60 ng/ml TGFß1 for 24 hours before and after the 
removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+. B. C. Arithmetic means (± SEM, n = 46 - 59 
cells) of the peak (B) and slope (C) of the change in intracellular Ca2+ concentrations in megakaryocytes after removing 
extracellular Na+ (0 Na+) and adding 2 mM Ca2+ at 40 mM K+ with and without a pretreatment of 20, 40 or 60 ng/ml 
TGFß1 for 24 hours. *** (p<0.001) refers to a statistically significant difference from untreated megakaryocytes 
(ANOVA).  (Al-Maghout, Pelzl et al. 2017) 
 
Fura-2 fluorescent dye was used to determine the cytosolic Ca+2 activity ([Ca+2]i) in order to 
study the activity of Na+/ Ca+2 exchanger in Megakaryocytes. The activity of this exchanger was 
able to be evaluated in each MEG01 treatment group and compared to other groups. The cytosolic 
Ca+2 activity was increased differently throughout the different treatment groups as a result of the 
activation of the reverse mode of Na+/ Ca+2 exchanger which leads to an influx of the extracellular 
calcium into the cell. The activation of the reverse mode of the Na+/ Ca+2 exchanger is carried out 
by replacing the Na+-containing extracellular standard ringer solution with a 0Na+-solution which 
in turn contains Ca+2. This change in extracellular solution triggers the reverse mode of the Na+/ 
Ca+2 exchanger. In order to selectively study NCX activity, the experiments were performed in the 
absence of extracellular K+.  As shown in Figure 3, only the Meg01 cells which were treated with 
60 ng/ml TGFß1 demonstrated statistically significant increase of NCX activity compared to the 
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control group, while treatment with 20 or 40 ng/ml TGFß1 didn’t show significant increase in the 
activity of NCX. 
In order to study the concentration dependence of TGFß1-stimulated activity of K+-dependent 
Na+/Ca2+ exchanger (NCKX), the change in cytosolic Ca2+ activity was studied after adding 40nM 
K+ to both extracellular solutions used to trigger the reverse mode of Na+/Ca2+ exchanger. Adding 
40nM K+ to both standard and 0Na+-solution served in providing the ability to detect the activity 
of NCKX and compare the cytosolic Ca2+ activity ([Ca2+]i resulting from NCKX in different 
treatment groups of MEG01 cells. As shown in Figure 4, the Meg01 cells which were treated with 
60 ng/ml TGFß1 were the only group that demonstrated statistically significant increase of K+-
dependent Na+/Ca2+ exchanger NCKX activity compared to the control group. Treatment of 
MEG01 cells with 20 or 40 ng/ml TGFß1 didn’t show significant increase in the activity of NCKX. 
The second step of the study was to explore the time course of the TGFß1-stimulated 
Na+/Ca2+ exchangers activity.  
After studying the concentration dependence of TGFß1-stimulated Na+/Ca2+ exchangers 
activity, the TGFß1 concentration of 60ng/mL was adopted for further investigations for both NCX 
and NCKX in Meg01 cells. 
In order to study the time course of the effect of TGFß1, the cytosolic Ca2+ activity ([Ca2+]i) 
of untreated control MEG01 cells was compared to [Ca2+]i of other groups of MEG01 cells treated 
with 60ng/mL TGFß1 but for different periods of time, including: 6, 12 or 24 hours. 
The activity of K+-independent Na+/Ca2+ exchangers (NCX) was explored by using 0 K+ 
extracellular solutions when performing cytosolic calcium activity measurements. As shown in 
Figure 5, only the Meg01 cells which were treated with 60 ng/ml TGFß1 for 24 hours demonstrated 
statistically significant increase of NCX activity compared to the control group, while treatment 
with 60 ng/ml TGFß1 for 6 or 12 hours didn’t show significant increase in the activity of K+ 
independent Na+/ Ca2+ exchanger NCX. 
By using K+-containing extracellular solution during the measurement of cytosolic Ca2+ 
activity ([Ca2+]i , the time course of TGFß1-stimulated K+-dependent Na+/Ca2+ exchangers activity 
was elucidated. 
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Figure. 5. Time dependence of TGFß1-stimulated increase of Ca2+ entry mediated by NCX in megakaryocytes. (Al-
Maghout, Pelzl et al. 2017) A. Representative original tracings illustrating intracellular Ca2+ concentrations in 
megakaryocytes loaded in Fura-2/ AM for 20-60 minutes with and without a pretreatment of 60 ng/ml TGFß1 for 6, 
12 or 24 hours before and after the removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+. 
B, C. Arithmetic means (± SEM, n = 40 - 52 cells) of the peak (B) and slope (C) of the change in intracellular Ca2+ 
concentrations in megakaryocytes after removing extracellular Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+ with 
and without a pretreatment of 60 ng/ml TGFß1 for 6, 12 or 24 hours. *** (p<0.001) refers to a statistically significant 
difference from untreated control group of megakaryocytes (ANOVA). (Al-Maghout, Pelzl et al. 2017) 
 
 
As shown in Figure 6, the Meg01 cells which were treated with 60 ng/ml TGFß1 for 24 hours 
were the only group that demonstrated statistically significant increase of K+-dependent 
Na+/Ca2+ exchanger (NCKX) activity compared to the control group. Treatment of MEG01 cells 
with 60 ng/ml TGFß1 for 6 or 12 hours didn’t show significant increase in the activity of NCKX. 
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Figure. 6. Time dependence of TGFß1-stimulated increase of Ca2+ entry mediated by NCKX in megakaryocytes. (Al-
Maghout, Pelzl et al. 2017) 
A. Representative original tracings illustrating intracellular Ca2+ concentrations in megakaryocytes loaded in Fura-2/ 
AM for 20-60 minutes with and without a pretreatment of 60 ng/ml TGFß1 for 6, 12 or 24 hours before and after the 
removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+.  
B, C. Arithmetic means (± SEM, n = 40 - 52 cells) of the peak (B) and slope (C) of the change in intracellular Ca2+ 
concentrations in megakaryocytes after removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 40 mM K+ with and 
without a pretreatment of 60 ng/ml TGFß1 for 6, 12 or 24 hours. *** (p<0.001) refers to a statistically significant 
difference from untreated control group of megakaryocytes (ANOVA) (Al-Maghout, Pelzl et al. 2017) 
 
3.2. TGFß1 Increases the Expression of Certain NCX and NCKX 
Isoforms 
 
After elucidating the concentration and time dependence of the TGFß1-induced activity of 
Na+/Ca2+ exchangers, Treatment of Meg-01 cells with 60 ng/ml of TGFβ1 for 24 hours was 
adopted for further investigation of the isoforms and mechanisms involved TGFß1 activity. 
RT-PCR was utilized in order to define the NCX and NCKX isoforms which undergoes 
upregulation of expression in response to pretreatment with TGFß1. As illustrated in Figure 7, the 
treatment of Meg01 cells by 60 ng/ml TGFß1 for 24 hours resulted in a significant stimulation of 
38 
 
the expression of several NCX and NCKX isoforms, including: NCX1, NCKX1, NCKX2 and 
NCKX5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 7. TGFß1-induced expression of NCX and NCKX isoforms in megakaryocytes (Al-Maghout, Pelzl et al. 
2017). A-F: Arithmetic means (± SEM, n = 5-11 preparations) of (A) NCX1, (B) NCX3, (C) NCKX1, (D) NCKX2, 
and (E) NCKX5, (F) NCKX6 over GAPDH transcript levels in megakaryocytes with and without a treatment of 60 
ng/ml TGFß1 for 24 hours. *(p<0.05), ** (p<0.01) refer to a statistically significant difference from untreated control 
group of megakaryocytes (student´s t-test) (Al-Maghout, Pelzl et al. 2017). 
 
3.3. P38 Kinase Mediates the Role of TGFß1 in Upregulating Activity and 
Expression of Na+/Ca2+ Exchangers 
 
In order to detect the role of p38 kinase in the regulation of the TGFß1-induced activity and 
expression of Na+/Ca2+ exchangers, Skepinone-L (1 μM), which is a p38 kinase inhibitor was 
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utilized. TGFß1 activity in up-regulating Na+/Ca2+ exchangers activity and transcript was observed 
with the presence or absence of p38 kinase inhibitor, Skepinone-L. 
As shown in Figure 8, treatment with 60 ng/ml TGFß1 for 24 hours increased the expression 
of NCX1, NCKX1, NCKX2, and NCKX5 significantly in the absence of Skepinone-L; whereas 
in the presence of Skepinone-L, the expression of those isoforms was not upregulated, as 
Skepinone-L can, by inhibiting p38 kinase, preclude the role of TGFß1 in upregulating 
transcription levels of those isoforms.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 8. Inhibition of p38 kinase by Skepinone-L abrogates the TGFß1-induced expression of NCX1, NCKX1, 
NCKX2, and NCKX5 isoforms in megakaryocytes (Al-Maghout, Pelzl et al. 2017). A-D: Arithmetic means (± SEM, 
n = 4-11 preparations) of (A) NCX1, (B) NCKX1, (C) NCKX2, and (D) NCKX5 over GAPDH transcript levels in 
megakaryocytes with and without a pretreatment with 60 ng/ml TGFß1 for 24 hours in the absence or presence of p38 
kinase inhibitor Skepinone-L (1 μM). *(p<0.05), ** (p<0.01) refer to a statistically significant difference from 
untreated control group of megakaryocytes, § (p<0.05), §§ (p<0.01) refer to a statistically significant difference from 
megakaryocytes treated with TGFß1 alone (student´s t-test) (Al-Maghout, Pelzl et al. 2017). 
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The activity of K+ independent Na+/Ca2+ exchanger NCX was significantly increased as a 
result of the treatment with 60ng/ml TGFß1 for 24 hours, but in the presence of p38 kinase inhibitor 
Skepinone-L the effect of TGFß1 is abrogated. (Figure. 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 9. Inhibition of p38 kinase by Skepinone-L abrogates the TGFß1-induced Ca2+ entry mediated by NCX in 
megakaryocytes (Al-Maghout, Pelzl et al. 2017).  
A. Representative original tracings illustrating intracellular Ca2+ concentrations in megakaryocytes loaded in Fura-2/ 
AM for 20-60 minutes with and without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with p38 
kinase inhibitor Skepinone-L (1 μM) before and after the removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 
mM K+.  
B, C.  Arithmetic means (± SEM, n = 32 - 36 cells) of the peak (B) and slope (C) of the change in intracellular Ca2+ 
concentrations in megakaryocytes after removing external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+ with and 
without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with p38 kinase inhibitor Skepinone-L (1 
μM). *** (p<0.001) refers to a statistically significant difference from untreated control group of megakaryocytes 
(ANOVA), §§ (p<0.01), §§§ (p<0.001) refer to statistically significant difference from megakaryocytes treated with 
TGFß1 alone (ANOVA) (Al-Maghout, Pelzl et al. 2017). 
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The activity of K+-dependent Na+/Ca2+ exchanger NCKX was also significantly upregulated 
after 24 hours of treatment with 60ng/ml TGFß1, but in the presence of p38 kinase inhibitor 
Skepinone-L the effect of TGFß1 is abrogated on NCKX also. (Figure. 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 10. Inhibition of p38 kinase by Skepinone-L abrogates the TGFß1-induced Ca2+ entry mediated by NCKX in 
megakaryocytes (Al-Maghout, Pelzl et al. 2017).  
A. Representative original tracings illustrating intracellular Ca2+ concentrations in megakaryocytes loaded in Fura-2/ 
AM for 20-60 minutes with and without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with p38 
kinase inhibitor Skepinone-L (1 μM) before and after the removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 
40 mM K+.  
B, C.  Arithmetic means (± SEM, n = 32 - 36 cells) of the peak (B) and slope (C) of the change in intracellular Ca2+ 
concentrations in megakaryocytes after removing external Na+ (0 Na+) and adding 2 mM Ca2+ at 40 mM K+ with and 
without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with p38 kinase inhibitor Skepinone-L (1 
μM). *** (p<0.001) refers to a statistically significant difference from untreated control group of megakaryocytes 
(ANOVA), §§ (p<0.01) refers to a statistically significant difference from megakaryocytes treated with TGFß1 alone 
(ANOVA) (Al-Maghout, Pelzl et al. 2017). 
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3.4. SGK1 Mediates the Role of TGFß1 in Upregulating the 
Activity of Na+/Ca2+ Exchangers 
 
In order to detect the role of SGK1 in the regulation of TGFß1-induced activity and expression 
of Na+/Ca2+ exchangers, GSK-650394 (10 μM), which is an SGK1 inhibitor was utilized. TGFß1 
activity in up-regulating Na+/Ca2+ exchangers activity and transcript were observed with the 
absence or presence of SGK1 inhibitor GSK-650394. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 11. Inhibition of SGK1 by GSK-650394 abrogates the TGFß1-induced Ca2+ entry mediated by NCX in 
megakaryocytes (Al-Maghout, Pelzl et al. 2017). 
A. Representative original tracings illustrating intracellular Ca2+ concentrations in megakaryocytes loaded in Fura-2/ 
AM for 20-60 minutes with and without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with SGK1 
inhibitor GSK-650394 (10 μM) before and after the removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM 
K+.  
B, C. Arithmetic means (± SEM, n = 34 - 36 cells) of the peak (B) and slope (C) of the change in intracellular Ca2+ 
concentrations in megakaryocytes after removing external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+ with and 
without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with SGK1 inhibitor GSK-650394 (10 
μM). *** (p<0.001) refers to a statistically significant difference from untreated control group of megakaryocytes 
(ANOVA), §§§ (p<0.001), §§ (p<0.01) refer to statistically significant difference from megakaryocytes treated with 
TGFß1 alone (Al-Maghout, Pelzl et al. 2017). 
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As illustrated in Fig. 11, Treatment of Meg01 cells with 60 ng/ml TGFß1 for 24 hours 
upregulated the activity of NCX significantly in the absence of SGK1 inhibitor GSK-650394; 
whereas TGFß1 in the presence of GSK-650394 (10 μM) couldn’t upregulate the activity of NCX, 
as GSK-650394 can, by inhibiting SGK1, attenuate the role of TGFß1 in upregulating the activity 
of NCX. (Figure 11) 
As shown in Fig. 12, the activity of K+ dependent Na+/Ca2+ exchanger NCKX was also 
significantly upregulated after 24 hours of treatment with 60 ng/ml TGFß1, but in the presence of 
SGK1 inhibitor GSK-650394 (10 μM), the effect of TGFß1 was abrogated on NCKX also. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 12. Inhibition of SGK1 by GSK-650394 abrogates the TGFß1-induced Ca2+ entry mediated by NCKX in 
megakaryocytes (Al-Maghout, Pelzl et al. 2017). A. Representative original tracings illustrating intracellular Ca2+ 
concentrations in megakaryocytes loaded in Fura-2/ AM for 20-60 minutes with and without a pretreatment for 24 
hours with 60 ng/ml TGFß1 alone or TGFß1 with SGK1 inhibitor GSK-650394 (10 μM) before and after the removal 
of external Na+ (0 Na+) and adding 2 mM Ca2+ at 40 mM K+. B, C.  Arithmetic means (± SEM, n = 34 - 36 cells) of 
the peak (B) and slope (C) of the change in intracellular Ca2+ concentrations in megakaryocytes after removing 
external Na+ (0 Na+) and adding 2 mM Ca2+ at 40 mM K+ with and without a pretreatment for 24 hours with 60 ng/ml 
TGFß1 alone or TGFß1 with SGK1 inhibitor GSK-650394 (10 μM). *** (p<0.001) refers to a statistically significant 
difference from untreated control group of megakaryocytes (ANOVA), §§ (p<0.01) refers to a statistically significant 
difference from megakaryocytes treated with TGFß1 alone (Al-Maghout, Pelzl et al. 2017). 
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Treatment with TGFß1 increased the transcript levels encoding NCX1, NCKX1, NCKX2, and 
NCKX5 significantly in the absence of SGK1 inhibitor, GSK-650394, as well as in the presence 
of GSK-650394 (10 μM). The role of TGFß1 in increasing the expression of specific isoforms of 
NCX and NCKX was not affected significantly by GSK-650394. The alteration of Na+/Ca2+ 
exchanger activity caused by GSK-650394 was not aligned with a significant change in the 
transcript levels of genes encoding specific isoform of NCX and NCKX. 
 
 
3.5. NFκB Mediates the Role of TGFß1 in Upregulating the 
Activity of Na+/Ca2+ Exchangers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 13. Inhibition of NFκB by Wogonin abrogates the TGFß1-induced Ca2+ entry mediated by NCX in 
megakaryocytes (Al-Maghout, Pelzl et al. 2017).  
A. Representative original tracings illustrating intracellular Ca2+ concentrations in megakaryocytes loaded in Fura-2/ 
AM for 20-60 minutes with and without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with NFκB 
inhibitor Wogonin (100 μM) before and after the removal of external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+.  
B,C.  Arithmetic means (± SEM, n = 31 - 39 cells) of the peak (B) and slope (C) of the change in intracellular Ca2+ 
concentrations in megakaryocytes after removing external Na+ (0 Na+) and adding 2 mM Ca2+ at 0 mM K+ with and 
without a pretreatment for 24 hours with 60 ng/ml TGFß1 alone or TGFß1 with NFκB inhibitor Wogonin (100 μM). 
*** (p<0.001) refers to a statistically significant difference from untreated control group of megakaryocytes 
(ANOVA), §§ (p<0.01) §§§ (p<0.001) refer to statistically significant difference from megakaryocytes treated with 
TGFß1 alone (Al-Maghout, Pelzl et al. 2017). 
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Treatment of Meg01 cells with 60 ng/ml TGFß1 for 24 hours upregulated the 
activity of NCX significantly in the absence of NFκB inhibitor Wogonin; whereas 
TGFß1 in the presence of Wogonin couldn’t upregulate the activity of NCX, as 
Wogonin can, by inhibiting NFκB, abrogate the role of TGFß1 in upregulating the 
activity of NCX. (Figure 13) 
The activity of K+-dependent Na+/Ca2+ exchanger NCKX was also significantly 
upregulated after 24 hours of treatment with 60ng/ml TGFß1, but in the presence of 
NFκB inhibitor Wogonin, the effect of TGFß1 was abrogated on NCKX also. (Figure 
14)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 14. Inhibition of NFκB by Wogonin abrogates the TGFß1-induced Ca2+ entry mediated by NCKX in 
megakaryocytes (Al-Maghout, Pelzl et al. 2017). A. Representative original tracings illustrating intracellular Ca2+ 
concentrations in megakaryocytes loaded in Fura-2/ AM for 20-60 minutes with and without a pretreatment for 24 
hours with 60 ng/ml TGFß1 alone or TGFß1 with NFκB inhibitor Wogonin (100 μM) before and after the removal of 
external Na+ (0 Na+) and adding 2 mM Ca2+ at 40 mM K+. B, C.  Arithmetic means (± SEM, n = 31 - 39 cells) of the 
peak (B) and slope (C) of the change in intracellular Ca2+ concentrations in megakaryocytes after removing external 
Na+ (0 Na+) and adding 2 mM Ca2+ at 40 mM K+ with and without a pretreatment for 24 hours with 60 ng/ml TGFß1 
alone or TGFß1 with NFκB inhibitor Wogonin (100 μM). *** (p<0.001) refers to a statistically significant difference 
from untreated control group of megakaryocytes (ANOVA), §§ (p<0.01) refers to a statistically significant difference 
from megakaryocytes treated with TGFß1 alone (Al-Maghout, Pelzl et al. 2017). 
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Treatment with 60 ng/ml TGFß1 for 24 hours increased the transcript levels encoding NCX1, 
NCKX1, NCKX2, and NCKX5 significantly in the absence of NFκB inhibitor, Wogonin. In the 
presence of Wogonin (100 μM), the effect of TGFß1 in up-regulating the expression of specific 
isoforms of NCX and NCKX didn’t show significant change. The change of Na+/Ca2+ exchanger 
activity, in the presence of GSK-650394, was not aligned with a significant change in the transcript 
levels encoding NCX1, NCKX1, NCKX2, and NCKX5. 
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4. DISCUSSION 
 
In the present study, TGFß1 is shown to be an effective activator of Na+/Ca2+ 
exchangers in megakaryocytes. TGFß1 can upregulate Ca2+ entry or Ca2+ extrusion by 
Na+/Ca2+ exchange, as the exchanger plays a role in the mobility of Ca2+ in both 
directions. Depending on the gradient of Ca2+ and Na+, the Na+/Ca2+ exchanger can 
carry out Ca2+ extrusion at high levels of intracellular Ca2+ and/or hyperpolarized cell 
membrane potential; and on the contrary, in cases of high levels of intracellular Na+ 
and/or depolarized cell membrane the Na+/Ca2+ exchanger can accomplish Ca2+ entry 
(Roberts, Matsuda et al. 2012, Pulcinelli, Trifiro et al. 2013, Shumilina, Nurbaeva et al. 
2013). Na+/Ca2+ exchanger activity in both directions can be upregulated by TGFß1 
(Almilaji, Yan et al. 2016), TGFß1 has also a major role in regulating Ca2+ entry via 
Orai1 (Yan, Schmid et al. 2015). 
TGFß1 can simultaneously activate Orai1 to carry out Ca2+ entry and stimulate 
Na+/Ca2+ exchangers to extrude Ca2+. Through this concurrent dual activation of Ca2+ 
entry and Ca2+ extrusion, TGFß1 may trigger Ca2+ oscillations [39] which in turn play 
a role in regulating a variety of cellular functions (Parekh and Penner 1997, Lang, 
Busch et al. 1998, Berridge, Bootman et al. 2003). 
Ca2+ oscillations are also important for cell survival (Heise, Palme et al. 2010, 
Parkash and Asotra 2010) and during cell cycle (Steinhardt and Alderton 1988, Taylor, 
Zeng et al. 2008), as Ca2+ oscillations are important for the cell to develop into the 
synthesis phase (S phase) and the Metosis (M phase) of the cell cycle (Steinhardt and 
Alderton 1988, Taylor, Zeng et al. 2008). Both Ca2+ extrusion and Ca2+ entry are 
important for cell survival and development. The lack of Ca2+ extrusion leads to 
sustained increase of cytosolic Ca2+ activity as Ca2+ entry continues to increase 
intracellular Ca2+ levels which eventually stimulates apoptosis (Parekh and Penner 
1997, Berridge, Lipp et al. 2000, Towhid, Schmidt et al. 2013).  
In the present study, TGFß1 is found to up-regulate Na+/Ca2+ exchangers through 
certain isoforms of NCX and NCKX. Not only the involved isoforms have been 
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defined, but also the signaling pathway required for the accomplishment of the effect of 
TGFß1 has been explored. 
The effect of TGFß1 is found to be abrogated by a variety of elements, including: 
Skepinone-L (p38 kinase inhibitor), GSK-650394 (SGK1 inhibitor) and Wogonin 
(NFκB inhibitor). The inhibition of p38 kinase, SGK1 or NFκB is found to lead to the 
inhibition of TGFß1-stimulated up-regulation of Na+/Ca2+ exchangers. Thus, the effect 
of TGFß1 in this case is suggested to be carried out through the upregulation of p38 
kinase, which leads to the up-regulation of SGK1 (Borst, Schmidt et al. 2012), what in 
turn is followed by an activation of nuclear factor NFκB (Borst, Schmidt et al. 2012, 
Eylenstein, Schmidt et al. 2012). 
Through this mechanism TGFß1 can play a role in the direct regulation of 
intracellular Ca2+ activity in Megakaryocytes. In addition to this direct role, TGFß1 has 
also an indirect effect through its effect on Na+/K+ ATPase in megakaryocytes. TGFß1 
can through upregulating Na+/K+ ATPase affect the activity of Na+/Ca2+ exchangers 
indirectly and thus affect intracellular Ca2+ activity in Megakaryocytes indirectly, as 
up-regulating the Na+/K+ ATPase increases the Na+ gradient and potential difference, 
what activates Na+/Ca2+ exchangers and eventually leads to Ca2+ extrusion [57]. p38 
kinase, SGK1 and NFκB are also involved in this effect of TGFß1 on Na+/K+ ATPase 
(Hosseinzadeh, Schmid et al. 2014).  
TGFß1 is important for the maturation of megakaryocytes and the production of 
platelets (Sakamaki, Hirayama et al. 1999). The Megakaryocytic cell itself produce and 
release TGFß1 (Bock, Loch et al. 2005, Ponce, de Lourdes et al. 2012). 
Thrombopoietin, which plays a role in the regulation of platelet production, stimulates 
the expression of megakaryocytic TGFß receptors. The expression of thrombopoietin 
itself is stimulated by TGFß (Sakamaki, Hirayama et al. 1999). TGFß1 is thus a 
powerful regulator of megakaryopoiesis (Sakamaki, Hirayama et al. 1999) and 
excessive TGFß1 expression leads to myelofibrosis (Ponce, de Lourdes et al. 2012). 
In addition to the role of TGFß1 in several cellular functions in megakaryocytes 
including proliferation, maturation and survival, the effect of TGFß1 involves also the 
enhancement of functions in platelets. This includes the role of TGFß1 in enhancing 
Ca2+ entry via Orai1 in platelets in addition to enhancing Ca2+ entry and extrusion via 
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Na+/Ca2+ exchanger, which in turn boost the response of platelets for activators such as 
thrombin or collagen related peptide (Borst, Schmidt et al. 2012). 
In conclusion, TGFß1 has a role in up-regulating certain isoforms of Na+/Ca2+ 
exchanger in Megakaryocytes including NCX1, NCKX1, NCKX2 and NCKX5. 
TGFß1 plays a role in regulating the cytosolic calcium activity [Ca2+] in 
Megakaryocytes through a variety of mechanisms including upregulating Ca2+ 
extrusion by specific Na+/Ca2+ exchanger isoforms besides upregulating store operated 
Ca2+ entry. p38 kinase, SGK1 and NFκB are involved in the mechanism of which 
TGFß1 regulates the function of and Na+/Ca2+ exchange. 
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5. Summary 
 
Transforming Growth Factor ß1 (TGFß1) is produced and released by many cell 
types as it is expressed in a wide range of tissues. The cells that produce TGFß1 tend to 
have specific receptors for TGFß1. 
Megakaryocytes are one of those cells. TGFβ1 is produced and released by 
megakaryocytes, then it binds to its receptors on the membrane of Megakaryocytes and 
thus triggers signalling downstreams, and so TGFβ1 can be considered an autocrine 
regulator of megakaryocytes. The resulting effect of TGFβ1 on Megakaryocytes 
includes the activation of differentiation and eventually the formation of proplatelets. 
The production of platelets by megakaryocytes is controlled by a group of 
environmental and autocrine elements. The autocrine factors can be represented 
basically in the release of TGFß1 and adenosine diphosphate by human 
megakaryocytes which lead to an increase in cytosolic calcium concentration in 
megakaryocyte itself. 
Calcium release from intracellular stores and calcium entry from extracellular 
milieu into the cell are essential to the regulation of the functions of human 
megakaryocytes. 
TGFβ1, which is a key regulator of megakaryocyte maturation and platelet 
formation, up-regulates both, store operated Ca2+ entry (SOCE) and Ca2+ extrusion by 
Na+/Ca2+ exchangers. By upregulating SOCE, TGFβ1 thus enhances the increase of 
cytosolic Ca2+ activity ([Ca2+]i) caused by the release of Ca2+ from intracellular stores 
and later TGFβ1 enhances the following decline of [Ca2+]i by upregulating Na+/Ca2+ 
exchangers. 
P38 Mitogen-Activated Protein Kinase, Serum/Glucocorticoid Inducible kinase 
(SGK1) and Nuclear Factor κB (NFκB) are important components of the TGFβ1 
signaling pathway, which controls a variety of cellular functions. This pathway plays 
an important role in differentiation and proliferation of different cell types. 
The aim of the present study is to investigate whether P38 Kinase, SGK1 and NFκB play a 
role in the upregulation of Na+/Ca2+ exchanger activity and expression in Megakaryocytes 
following treatment with TGFß1. 
To conclude, TGFβ1 significantly upregulates transcription of certain isoforms of Na+/Ca2+ 
exchanger, namely: NCX1, NCKX1, NCKX2, and NCKX5 and thus TGFβ1 upregulates Na+/Ca2+ 
exchanger activity, an effect requiring p38 kinase, SGK1 and NFκB. 
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7. Contributions 
 
The present study describes the role of TGFβ1 in the regulation of Ca2+ signaling in 
Megakarycytes. The data included in this dissertation is mostly produced and collected from 
experiments I accomplished personally. Howerver, I obtained support from Basma Sukkar, Itishri 
Sahu and Lisann Pelzl in performing PCR and maintaining cultured megakaryocytic cells. 
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